Injection, Solution · Intramuscular

Neisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen, Neisseria Meningitidis Group C Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen, Neisseria Meningitidis Group Y Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen, And Neisseria Meningitidis Group W-135 Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen

Brands: Menquadfi · Neisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen + Neisseria Meningitidis Group C Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen + Neisseria Meningitidis Group W-135 Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen + Neisseria Meningitidis Group Y Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen

2 ACTIVE SUPPLIERS — US

openFDA · updated weekly

US2 NDCs
2 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATC—

RxCUI (US)2360572

US makers2 labelers

Packages4

DEA / ScheduleNone

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Sanofi Vaccines US Inc.	unknown	3	SUPPLYING
A-S Medication Solutions	unknown	1	SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.